tiprankstipranks
Trending News
More News >
Claritas Pharmaceuticals (CLAZF)
OTHER OTC:CLAZF
US Market

Claritas Pharmaceuticals (CLAZF) Stock Statistics & Valuation Metrics

Compare
25 Followers

Total Valuation

Claritas Pharmaceuticals has a market cap or net worth of $834.58K. The enterprise value is $1.12M.
Market Cap$834.58K
Enterprise Value$1.12M

Share Statistics

Claritas Pharmaceuticals has 37,786,587 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding37,786,587
Owned by Insiders
Owned by Institutions

Financial Efficiency

Claritas Pharmaceuticals’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)0.00
Return on Assets (ROA)0.00
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)0.00
Revenue Per Employee
Profits Per Employee
Employee Count
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Claritas Pharmaceuticals is 0.00. Claritas Pharmaceuticals’s PEG ratio is <0.01.
PE Ratio0.00
PS Ratio0.00
PB Ratio-0.12
Price to Fair Value0.00
Price to FCF-0.06
Price to Operating Cash Flow-0.06
PEG Ratio<0.01

Income Statement

In the last 12 months, Claritas Pharmaceuticals had revenue of 0.00 and earned 0.00 in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit0.00
Operating Income0.00
Pretax Income0.00
Net Income0.00
EBITDA0.00
Earnings Per Share (EPS)0.00

Cash Flow

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00

Dividends & Yields

Claritas Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta69.76
52-Week Price Change0.00%
50-Day Moving Average
200-Day Moving Average
Relative Strength Index (RSI)100.00
Average Volume (3m)1.50K

Important Dates

Claritas Pharmaceuticals upcoming earnings date is Jun 2, 2023, TBA (Confirmed).
Last Earnings DateNov 30, 2022
Next Earnings DateJun 2, 2023
Ex-Dividend Date

Financial Position

Claritas Pharmaceuticals as a current ratio of 0.00, with Debt / Equity ratio of -21.41%
Current Ratio0.00
Quick Ratio0.00
Debt to Market Cap0.00
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Claritas Pharmaceuticals has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Claritas Pharmaceuticals EV to EBITDA ratio is 0.00, with an EV/FCF ratio of 0.00.
EV to Sales0.00
EV to EBITDA0.00
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00

Balance Sheet

Claritas Pharmaceuticals has $0.00 in cash and marketable securities with $0.00 in debt, giving a net cash position of $0.00 billion.
Cash & Marketable Securities$0.00
Total Debt$0.00
Net Cash$0.00
Net Cash Per Share$0.00
Tangible Book Value Per Share$0.00

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for Claritas Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis